Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.
- Resource Type
- journal article
- Source
- Obesity (19307381); Jan2019, Vol. 27 Issue 1, p41-49, 9p
- Subject
OBESITY TYPE 2 diabetes RANDOMIZED controlled trials FATTY liver ADIPONECTIN COMPARATIVE studies GROWTH factors RESEARCH methodology MEDICAL cooperation POLYETHYLENE glycol RESEARCH EVALUATION research BLIND experiment - Language
- ISSN
- 19307381